Dr. Trevor Martin is the CEO and co-founder of Mammoth Biosciences, which addresses challenges across healthcare, agriculture, environmental monitoring, biodefense, and more through discovery of novel CRISPR systems to power the next generation of CRISPR-based synthetic biology products. Ursheet Parikh is a partner at the venture capital firm Mayfield, where he co-leads the Human and Planetary Health investment practice, which includes an investment in Mammoth. In this conversation with Stanford adjunct lecturer Ravi Belani, Martin and Parikh share their advice for building a platform biotech company with staying power.